WuXi Biologics Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, WuXi Biologics stock has a consensus rating of "Buy" and an average price target of $46.25. The average 1-year stock price forecast is 34.53% higher than the current stock price, while the lowest is $30.48 (-11.34%) and the highest is $78.16 (+127.34%).

Price Target: $46.25 (+34.53%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$30.48	$46.25	$45.81	$78.16
Change	-11.34%	+34.53%	+33.25%	+127.34%

Analyst Ratings

The average analyst rating for WuXi Biologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	21	20	17	17	16	16
Buy	5	5	5	5	5	5
Hold	4	4	4	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	30	29	26	27	25	25

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laurence Tam Morgan Stanley	Morgan Stanley	Buy Maintains $45.00 → $50.00	Buy	Maintains	$45.00 → $50.00	+45.43%	May 14, 2026
Unknown Analyst Citi No rating	Citi	Buy Maintains $42.00	Buy	Maintains	$42.00	+22.16%	Apr 13, 2026
Unknown Analyst Zhongtai Securities No rating	Zhongtai Securities	Buy Maintains $50.10 → $50.30	Buy	Maintains	$50.10 → $50.30	+46.31%	Apr 10, 2026
Unknown Analyst Guotai Haitong No rating	Guotai Haitong	Buy Maintains $54.49	Buy	Maintains	$54.49	+58.49%	Apr 7, 2026
Unknown Analyst CICC No rating	CICC	Buy Maintains $45.00 → $48.00	Buy	Maintains	$45.00 → $48.00	+39.62%	Mar 27, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.